Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.07 EUR
−219.48 M EUR
99.94 M EUR
29.65 M
About Agenus Inc.
Sector
Industry
CEO
Garo H. Armen
Website
Headquarters
Lexington
Founded
1994
ISIN
US00847G8042
FIGI
BBG00LTP29H6
Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AJ8 is 3.66 EUR — it has increased by 1.12% in the past 24 hours. Watch Agenus Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Agenus Inc. stocks are traded under the ticker AJ8.
AJ8 stock has risen by 7.78% compared to the previous week, the month change is a −1.10% fall, over the last year Agenus Inc. has showed a −44.96% decrease.
We've gathered analysts' opinions on Agenus Inc. future price: according to them, AJ8 price has a max estimate of 19.65 EUR and a min estimate of 5.13 EUR. Watch AJ8 chart and read a more detailed Agenus Inc. stock forecast: see what analysts think of Agenus Inc. and suggest that you do with its stocks.
AJ8 stock is 4.57% volatile and has beta coefficient of 2.35. Track Agenus Inc. stock price on the chart and check out the list of the most volatile stocks — is Agenus Inc. there?
Today Agenus Inc. has the market capitalization of 112.96 M, it has increased by 8.05% over the last week.
Yes, you can track Agenus Inc. financials in yearly and quarterly reports right on TradingView.
Agenus Inc. is going to release the next earnings report on Nov 11, 2025. Keep track of upcoming events with our Earnings Calendar.
AJ8 earnings for the last quarter are −0.85 EUR per share, whereas the estimation was 2.05 EUR resulting in a −141.32% surprise. The estimated earnings for the next quarter are 1.87 EUR per share. See more details about Agenus Inc. earnings.
Agenus Inc. revenue for the last quarter amounts to 21.82 M EUR, despite the estimated figure of 42.20 M EUR. In the next quarter, revenue is expected to reach 68.51 M EUR.
AJ8 net income for the last quarter is −23.73 M EUR, while the quarter before that showed −23.35 M EUR of net income which accounts for −1.61% change. Track more Agenus Inc. financial stats to get the full picture.
No, AJ8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 8, 2025, the company has 316 employees. See our rating of the largest employees — is Agenus Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Agenus Inc. EBITDA is −66.61 M EUR, and current EBITDA margin is −107.37%. See more stats in Agenus Inc. financial statements.
Like other stocks, AJ8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Agenus Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Agenus Inc. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Agenus Inc. stock shows the neutral signal. See more of Agenus Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.